Craig Malzahn

CIK: 0002062007

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RGNX

REGENXBIO Inc.

Discretionary Trading P&L

Holdings

Transaction History (5 total)

RGNX
REGENXBIO Inc.
Nov 1, 2026
Award(A)
Direct
27.8K shares-
RGNX
REGENXBIO Inc.
Sep 1, 2026
Tax Payment(F)
Direct
234 shares at avg. $9.32$2K
RGNX
REGENXBIO Inc.
Jan 6, 2026
Award(A)
Direct
65.8K shares-
RGNX
REGENXBIO Inc.
Jan 2, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $14.40$18K
RGNX
REGENXBIO Inc.
Sep 1, 2025
Tax Payment(F)
Direct
234 shares at avg. $8.93$2K

		Type	Shares	Price		Ownership
Nov 1, 2026	RGNX REGENXBIO Inc.	Award(A)	27,777	-	$0	Direct
Sep 1, 2026	RGNX REGENXBIO Inc.	Tax Payment(F)	234	$9.32	$2,181	Direct
Jan 6, 2026	RGNX REGENXBIO Inc.	Award(A)	65,847	-	$0	Direct
Jan 2, 2026	RGNX REGENXBIO Inc.	Tax Payment(F)	1,238	$14.40	$17,827	Direct
Sep 1, 2025	RGNX REGENXBIO Inc.	Tax Payment(F)	234	$8.93	$2,090	Direct

1-5 of 5 transactions

About Malzahn Craig

Malzahn Craig (SEC CIK 0002062007) files insider reports with the SEC as Chief Technology Officer of REGENXBIO Inc. (RGNX).

Signal8 holds 6 ownership filings by Malzahn Craig (1 Form 3, 5 Form 4), filed between Mar 24, 2025 and Nov 3, 2026. Those filings report 5 transactions, from Sep 1, 2025 to Nov 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Malzahn Craig's filings is in ROCKVILLE, MD.

Recent filings by Malzahn Craig

Nov 1, 2026: Grant or award of RGNX shares (Form 4, code A).
Sep 1, 2026: Tax withholding of RGNX shares (Form 4, code F).
Jan 6, 2026: Grant or award of RGNX shares (Form 4, code A).
Jan 2, 2026: Tax withholding of RGNX shares (Form 4, code F).
Sep 1, 2025: Tax withholding of RGNX shares (Form 4, code F).

Other insiders filing for REGENXBIO Inc. (RGNX)

Christmas Patrick J., Chief Strategy & Legal Officer
PAKOLA STEVE, Chief Medical Officer
Chan Mitchell, Chief Financial Officer
Ciongoli Gregory Austin, Director
Simpson Curran, Chief Executive Officer
Tasse Daniel, Director

How to read Form 4 transaction codes